Allergan Says Asacol Buyers' Generic-Delay Suit Defective
By Matt Bernardini · May 13, 2019, 5:44 PM EDT
Allergan is seeking to end a suit brought by buyers of its ulcerative colitis drug who allege a company subsidiary sought to delay generic competition, telling a Massachusetts federal court the...
To view the full article, register now.